Your browser doesn't support javascript.
loading
Pharmacokinetics and safety of a single dose of telavancin in pediatric subjects 2-17 years of age.
Bradley, John S; Goldman, Jennifer L; James, Laura P; Kaelin, Byron; Gibson, Breanne H Y; Arrieta, Antonio.
Affiliation
  • Bradley JS; Department of Pediatrics, University of California San Diego School of Medicine and Rady Children's Hospital , San Diego, California, USA.
  • Goldman JL; Department of Pediatrics, University of Missouri-Kansas City and Children's Mercy Hospital , Kansas City, Missouri, USA.
  • James LP; Department of Pediatrics, Arkansas Children's Hospital Research Institute , Little Rock, Arkansas, USA.
  • Kaelin B; Product Development, Cumberland Pharmaceuticals Inc. , Nashville, Tennessee, USA.
  • Gibson BHY; Product Development, Cumberland Pharmaceuticals Inc. , Nashville, Tennessee, USA.
  • Arrieta A; Division of Infectious Diseases, Children's Hospital of Orange County , Orange County, California, USA.
Antimicrob Agents Chemother ; 67(11): e0098723, 2023 11 15.
Article in En | MEDLINE | ID: mdl-37815398
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Aminoglycosides / Anti-Bacterial Agents Limits: Adult / Child / Humans Language: En Journal: Antimicrob Agents Chemother Year: 2023 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Aminoglycosides / Anti-Bacterial Agents Limits: Adult / Child / Humans Language: En Journal: Antimicrob Agents Chemother Year: 2023 Type: Article Affiliation country: United States